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Explaining the Unexplained
Causes of Syncope
Are We There Yet?*
Niraj Mehta, MD,
Maria Zildany Pinheiro Tavora, MD,
Carlos A. Morillo, MD
Hamilton, Ontario, Canada
When you have eliminated the impossible, whatever remains,
however improbable, must be the truth.
—Sherlock Holmes, The Sign of Four (1)
Determining the cause of recurrent unexplained syncope
remains a clinical challenge and a permanent quest. Guide-
lines and multiple studies emphasize that a clear deductive
method based on a thorough interrogation and examination
can usually disclose the etiology of syncope in the majority
of cases (2). Nonetheless, in daily clinical practice, applying
a simple comprehensive diagnostic approach to the patient
that manifests with syncope remains an unmet goal. From a
practical perspective, the main goals when evaluating the
patient with recurrent syncope are simple: 1) establish a
diagnosis and prognosis; and 2) implement therapy. As
simple as this may sound, the reality is that in clinical
practice, the strategy for evaluation of the patient with
recurrent syncope is inconsistent and usually leads to mul-
tiple, low-yield, costly, and unnecessary testing and unwar-
ranted hospital admissions (2).
See page 167
It is of critical importance to initially determine whether
the transient loss of consciousness is actually due to syncope
and not other causes (i.e., seizures, functional, or other rare
causes). By and large, syncope is the most common cause of
transient loss of consciousness. Once it has been established
that the patient has true syncope, it is useful to further
classify the etiology of syncope into 4 categories: 1) reflex
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have no relationships to disclose.neurally mediated; 2) cardiac causes; 3) orthostatic hypoten-
sion; and 4) unexplained (2). In the last category are those
patients who underwent extensive investigations (including
electrophysiological studies and neurological work-up) without
revealing the cause of syncope (2). In patients with electrocar-
diographic (ECG) abnormalities (bundle branch block, fascic-
ular block, prolonged PR interval), particularly those over the
age of 65 years, bradycardia is the most plausible cause of
unexplained syncope, as several studies using the implantable
loop recorder (ILR) have revealed (3). The patient with
ecurrent unexplained syncope with a pristine ECG, little or no
vidence of structural heart disease, and a clinical presentation
hat is not in keeping with neurally mediated reflex syncope
emains part of a challenging group. In this subgroup of
atients, the diagnostic strategy usually calls for the early use of
he ILR (2).
The ILR, initially developed by the group at the Univer-
ity of Western Ontario in 1992, has provided important
nsight into the mechanisms of unexplained syncope (4).
imilarly, the ISSUE (International Study of Syncope of
ncertain Etiology) studies have provided unique insights
nto the mechanisms of neurally mediated reflex responses
nd paroxysmal atrioventricular (AV) block (3,5). In brief,
f patients with syncope and no structural heart disease with
ither a positive or negative tilt test, 34% had recurrent
yncope, with the most frequent finding being 1 or more
rolonged asystolic pauses, mainly due to sinus arrest (46%
f the isolated syncope group and 62% of the tilt-positive
atients). Conversely, in patients with bundle branch block
nd syncope, 42% had recurrence, related almost invariably
ith AV block (5).
In this issue of the Journal, Brignole et al. (6) further
xpand our knowledge of unraveling the mysteries of unex-
lained syncope. In a series of 18 patients (mean age 55 
9 years) from 4 centers in Europe who presented with a
ong-standing history of recurrent unexplained syncope (8
7 years) and an otherwise normal heart, the authors
eport that idiopathic paroxysmal AV block is the most
ikely guilty suspect. The patients studied had the following
haracteristics: 1) normal ECG; 2) absence of structural
eart disease; and 3) ECG documentation of paroxysmal
hird-degree AV block. Prolonged ECG (primarily ILR)
ocumented the presence of third-degree AV block of
brupt onset in all patients. The known mechanisms related
ith paroxysmal AV block are, namely, intrinsic disease of
he AV node conduction system or a neurally mediated
agal reflex response. As discussed by the authors, the
ormer is unlikely as the reported patients did not have
vidence of structural heart disease or conduction disorders,
s supported by an unremarkable electrophysiological eval-
ation in the vast majority of these cases. The possibility of
neurally mediated vagal reflex paroxysmal AV block
sually requires the presence of sinus arrest or sinus brady-
ardia preceding the syncopal episodes. Detailed ECG
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significant P-P cycle or PR-interval prolongations preced-
ing the AV block, probably ruling out a vagally mediated
effect. If neither of the described mechanisms was respon-
sible for this paroxysmal AV block, are we then witnessing
the discovery of a new cause of unexplained syncope?
Holmesian deduction would suggest that, in fact, “When
you have eliminated the impossible, whatever remains,
however improbable, must be the truth.” So, are we in the
midst of the description of a new clinical entity, namely,
“idiopathic paroxysmal AV block?” Let us explore with
further detail who are these patients reported herein. Are
there any clinical features in common that would guide us as
clinicians to suspect this new clinical entity as a cause of
recurrent unexplained syncope? The population included in
this report is heterogeneous with a large age range (13 to 85
years), 5 patients had 3 or fewer syncopal episodes in their
lifetime, and most (15 of 18) had no prodromes or clear
autonomic triggers at the time of the syncopal episodes.
There was no evidence of any ECG abnormalities or
structural heart disease. The electrophysiological study was
normal in 12 of 15 patients who had the test performed, and
tilt-table testing was abnormal in 8 of 17 (47%). Almost
one-half of the patients who had a tilt test had a neurally
mediated reflex response triggered. It is well known that the
specificity and sensitivity to detect both sinus node and AV
node conduction disturbances by electrophysiological study
is limited even in the presence of documented paroxysmal
AV block (7). Additionally, the tilt test also has limited
specificity, and the provocation of a neurally mediated reflex
does not fully prove or disprove the cause of syncope. So, we
are left with no clinical clues that would lead the astute
clinician to deduct or suspect the diagnosis of idiopathic
paroxysmal AV block.
As should be expected by a deductive group, Brignole et
al. (6) had an ace up their sleeves. It is unclear whether the
investigators consciously or serendipitously drew adenosine
plasmatic levels in these patients. Notwithstanding, the
observation of consistently and significantly reduced levels
of adenosine is the only common thread in this population
of patients and may provide some hypothetic insight into
the mechanism of this disorder. Furthermore, the adminis-
tration of adenosine in a bolus injection disclosed significant
abnormalities in 16 of 18 (88%) patients, primarily due to
AV block with long pauses ranging between 3.3 and 25 s.
The authors are not very enthusiastic about this finding and
rightfully suggest that further studies are needed to deter-
mine the role of plasmatic adenosine and the adenosine test
to aid in the diagnosis of idiopathic paroxysmal AV block.
In light of the current recommendations from the European
Society of Cardiology syncope guidelines regarding the
adenosine test (Class III), it may well be that this entity may
resurrect this simple but difficult to interpret diagnostic test
(2). Speculation that chronic low adenosine plasma levels,
may lead to up-regulation of high-affinity adenosine A1
receptors and thereby lead to a hypersensitive AV noderesponse to adenosine is attractive but awaits further proof.
These observations pose the question of whether this entity
is part of the spectrum of neurally mediated reflex responses
modulated by chronic purinergic receptor down-regulation
cannot be fully eliminated; however, using the Holmesian
deductive methodology, this appears rather improbable.
As initially discussed, the main goals of the assessment of
the patient with recurrent unexplained syncope are to establish
a diagnosis and prognosis, and implement therapy. In this
particular case, the only obvious method of establishing the
diagnosis is the direct correlation of paroxysmal AV block with
syncope. This objective is clearly achieved by prolonged ECG
monitoring, preferably by means of an ILR. Therefore, it is
clear and supported by evidence that the early use of prolonged
ECG monitoring in patients with the characteristics described
by Brignole et al. (6) may be the best diagnostic strategy. The
role of adenosine plasmatic levels and the potential that the
adenosine test may in fact be useful in this population is an
attractive possibility, but remains to be explored in future cases
of idiopathic paroxysmal AV block. The prognosis of this
entity appears to be quite benign as none of these patients had
complete AV block during the relatively prolonged follow-up
period (mean 4 years). This benign course raises the question
whether some of these patients had some unusual form of
reflex-mediated paroxysmal AV block, particularly in the 4
patients 45 years of age.
Finally, the ultimate goal of describing a new clinical
entity is to provide a treatment that reduces or eliminates
the symptoms. In the series reported by Brignole et al. (6),
17 of 18 patients received a dual-chamber pacemaker, with
complete resolution of symptoms in all patients and no
recurrence of syncope or presyncope. Is a permanent dual-
chamber pacemaker then, the treatment of choice for this
new entity? Analyzing in detail, the population reported
that 8 of 17 patients paced had a burden of syncope of 4 or
fewer syncopal episodes in their lifetime. Furthermore, 4 of
these patients had only 2, and some had a single episode of
syncope during their lifetime. Of note, a 13-year-old patient
with a single episode of syncope and a pause of 3.5 s was
committed to permanent pacing. The only patient who
declined pacing therapy was, interestingly, the patient with
the highest burden of syncope (very frequent) and a pause of
4.5 s, remaining completely asymptomatic during 1.7 years
of follow-up. The authors provide no information on the
potential complications of pacing (i.e., lead dislodgement,
infection, and so forth), pacing programmability, and per-
cent time of pacing. It is interesting that all patients became
completely asymptomatic after pacing, particularly for par-
oxysmal AV block that was not preceded by bradycardia but
instead was of abrupt onset. In this setting, one would expect
that in some instances, depending on the lower rate pro-
grammed, some of these patients may have aborted syncope
but still have some episodes of presyncope. On that basis, it is
possible that permanent pacing is the therapy of choice, but
further studies are certainly needed to prove their efficacy in
patients with idiopathic paroxysmal AV block.
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awakens mixed responses that vary from immediate adop-
tion to overt skepticism. Many questions arise from descrip-
tions of new clinical entities; how frequent is this entity,
how do we identify these patients, and how do we treat
them? Brignole et al. (6) should be congratulated for
describing this new entity in detail, and they raise important
issues that should alert clinicians to think of the diagnostic
possibility of idiopathic paroxysmal AV block in patients
with recurrent unexplained syncope, with no evidence of
structural heart disease, and a normal ECG. Early adoption
of a prolonged ECG strategy, possibly with an ILR, is
recommended, and the role of adenosine levels and the role
of the adenosine test as a diagnostic tool in this population
remain to be determined. Permanent pacemaker therapy
may be the treatment of choice, but certainly more studies
need to be performed to establish the true efficacy of this
therapy given the benign prognosis from the patients
described by Brignole et al. (6). In true Holmesian deductive
reasoning, it appears “elementary” that we are presented
with new evidence for idiopathic paroxysmal AV block as a
potential cause of unexplained syncope, thereby unraveling
another mystery in the syncope saga.Reprint requests and correspondence: Dr. Carlos A. Morillo,
Arrhythmia and Pacing Service, David Braley CVSRI, PHRI
Room 3C-120, 237 Barton Street East, Hamilton, Ontario L8L
2X2, Canada. E-mail: morillo@hhsc.ca.
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